UnitedHealth CEO Stephen Hemsley said his firm is well-positioned to handle new policy changes that come out of Washington. » Read More
By: Dan Mangan
A new analysis looks at the fallout of a repeal bill previously proposed by Donald Trump's pick to head the federal health department. » Read More
By: Jake Novak
Tom Price's confirmation chances now seem weaker than any other Trump pick, Jake Novak explains why. » Read More
By: Mark Murray
Half of those in a new poll say they have little confidence that GOP proposals to replace the law will make things better, NBC News reports. » Read More
UnitedHealth on Tuesday posted quarterly earnings that beat expectations.
UnitedHealth will be the first major health insurer to report earnings, as Republicans have taken steps toward the repeal and replacement of Obamacare.
Federal health regulators are concerned that dialysis patients are being steered into private insurance as opposed to Medicare or Medicaid.
Price and Rep. Chris Collins, R-N.Y., got a 12 percent discount in their private placement purchase of stock in an Australian drug company.
Ryan's claims that Obamacare is failing are disputed by the White House, which points to a record sign-up pace for health plans.
The Senate voted early Thursday to take the first real step toward repealing Obamacare — a top goal of congressional Republicans.
Repealing Obamacare would provide a tax cut averaging $7 million for the 400 highest-earning taxpayers, according to a new study.
Morgan Stanley's 2020 earnings-per-share estimate for Merck is $5.82 versus the Wall Street consensus of $4.97.
Trump's Obamacare remarks came at a news conference that was his first since being elected president of the United States.
The iShares Nasdaq Biotechnology ETF (IBB) briefly fell more than 2.5 percent, tracking for its first negative day of 2017.
More than $19 billion was given to 5.2 million people to reduce their insurance premiums in 2015.
Nygren, who manages $16 billion as part of the Oakmark Fund, reveals his favorite health-care stocks for 2017.
"I truly understand the outrage when you have no idea what something's going to cost," said Heather Bresch.
Crafting and passing a replacement plan for Obamacare is seen as very difficult, if not impossible, in the short term.
Scientists have repeatedly said there is no link between autism and vaccinations.
Valeant has recently been trying to sell off its noncore assets to reduce its acquired mass amounts of debt.
Get the best of CNBC in your inbox